<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00637260</url>
  </required_header>
  <id_info>
    <org_study_id>820117</org_study_id>
    <nct_id>NCT00637260</nct_id>
  </id_info>
  <brief_title>Motor Cortex Stimulation for Parkinson's Disease</brief_title>
  <official_title>Motor Cortex Stimulation for Parkinson's Disease. A Prospective Double Blind Randomized Study With Cross-over</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic University, Italy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep Brain Stimulation represents the golden standard for surgical treatment of Parkinson
      disease (PD), but it is not optimally effective for controlling every motor sign and adverse
      events are not so infrequent Therefore, other approaches should be considered.We identified
      the motor cortex as a possible candidate and therefore we propose a double-blind randomized
      prospective study in 20 Parkinson patients in order:

        -  to test the efficacy of epidural motor cortex stimulation in Parkinson disease (primary
           endpoint: UPDRS III at 12 months at the end of the cross-over)

        -  to find out optimal electrode position and optimal stimulation parameters
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      20 Parkinsonian patients will be enrolled. After implantation of a bilateral strip electrode
      (Resume, Medtronic) over the motor cortex, after setting of optimal stimulation parameters,
      and after implantation of a neurostimulator, Medtronic, the patient will be randomly assigned
      to group A (Motor cortex stimulation on) or to group B ( sham stimulation) for 6 months.
      Randomization will be based on the output of a program based on a random number generation
      function that will output a 0 or 1 with a 50% chance of having a 1.

      At the 6 months visit, a cross-over is scheduled: group A will receive sham stimulation and
      group B will receive stimulation of the motor cortex for the next 6 months. In group A, the
      stimulation of the motor cortex will be resumed before the end of the 6 month sham
      stimulation, when the clinical status of the patient will come back to the status quo ante
      (UPDRS score equal to baseline pre-implant score).

      Both the patients and the evaluating neurologists and neuropsychologists will be blind; only
      the neurosurgeon will know the state of the stimulator (on or off) and the position and
      parameters of MCS.

      At 12 months, all the patients will be programmed as stimulation on and followed up for
      further 18 months. At 30 months visit, the clinical evaluation will be performed in on
      stim-on med, on stim-off med conditions; then the stimulator will be switched off for 1 month
      and the clinical evaluation will be repeated in off stim-off med and off stim-on med
      conditions.

      The primary endpoint will be the UPDRS III at 12 months (end of the cross over), and
      subsequently at 18 and 30 months. We will compare the clinical results with the precise site
      of the stimulating electrodes and we will try to correlate the clinical results with the
      amount of inhibition induced by motor cortex stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>UPDRS III</measure>
    <time_frame>12 months - end of crossover</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>UPDRS III</measure>
    <time_frame>18, 30 and 31 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UPDRS</measure>
    <time_frame>6,12, 18, 30, 31 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parkinson's disease quality of life scale(PDQL)</measure>
    <time_frame>6, 12, 18, 30, 31 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological and mood evaluation</measure>
    <time_frame>6, 12, 18, 30 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug therapy</measure>
    <time_frame>6, 12, 18, 30, 31 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Motor cortex stimulation on.</intervention_name>
    <description>The parameters of stimulation will be: contact 0 cathode, contact 3anode, 120microsec, 80 Hz, subthreshold for any movement or sensation, usually 3-5Volts. The stimulator will be switched on, continuously.</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Motor cortex stimulation on</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>motor cortex stimulation off</intervention_name>
    <description>The parameters of stimulation will be: contact 0 cathode, contact 3 anode, 120microsec, 80 Hz, subthreshold for any movement or sensation, usually 3-5 volts. The stimulator will be switched off.</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Idiopathic PD as diagnosed by a neurologist - a movement disorders specialist,
             according to the Parkinson Disease Brain Bank criteria, with asymmetrical
             bradykinesia, rigidity, tremor and postural instability (at least 3 from the above)

          2. Significant clinical response to Levodopa (improvement of UPDRS motor score &gt; 20%).

          3. Disease duration &gt; 5 years

          4. Advanced stage of disease:

          5. UPDRS motor score in off condition &gt;/= 40/108

          6. Hoehn &amp; Yahr stage &gt;/= 3

          7. DBS surgery not indicated or expressly refused by the patient

          8. Antiparkinsonian therapy stable for at least one month prior to implant

          9. Capability to give informed consent to surgery and to the study.

        Exclusion Criteria:

          1. Severe cognitive impairment or dementia

          2. Psychiatric disturbances with the exception of mild anxiety or depression and
             drug-induced psychiatric symptoms (i.e. benign hallucinations)

          3. History of epilepsy or documented electroencephalographic abnormalities suggesting
             epilepsy

          4. Previous neurosurgery of the brain (DBS or lesioning of the basal ganglia, fetal
             tissue transplantation )

          5. Lack of informed consent

          6. History of drug or alcohol abuse

          7. Poor general conditions increasing surgical risk or severe illness with poor
             prognosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatrice Cioni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Cattolica Roma, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Meglio, Prof, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Università Cattolica Roma, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Università Cattolica - Policlinico Gemelli - Neurochirurgia Funzionale</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Cioni B. Motor cortex stimulation for Parkinson's disease. Acta Neurochir Suppl. 2007;97(Pt 2):233-8. Review.</citation>
    <PMID>17691309</PMID>
  </reference>
  <reference>
    <citation>Pagni CA, Altibrandi MG, Bentivoglio A, Caruso G, Cioni B, Fiorella C, Insola A, Lavano A, Maina R, Mazzone P, Signorelli CD, Sturiale C, Valzania F, Zeme S, Zenga F. Extradural motor cortex stimulation (EMCS) for Parkinson's disease. History and first results by the study group of the Italian neurosurgical society. Acta Neurochir Suppl. 2005;93:113-9.</citation>
    <PMID>15986739</PMID>
  </reference>
  <reference>
    <citation>Cioni B, Meglio M, Perotti V, De Bonis P, Montano N. Neurophysiological aspects of chronic motor cortex stimulation. Neurophysiol Clin. 2007 Dec;37(6):441-7. Epub 2007 Nov 1. Review.</citation>
    <PMID>18083500</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2008</study_first_submitted>
  <study_first_submitted_qc>March 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2008</study_first_posted>
  <last_update_submitted>September 1, 2015</last_update_submitted>
  <last_update_submitted_qc>September 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University, Italy</investigator_affiliation>
    <investigator_full_name>bEATRICE CIONI</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>motorcortex stimulation</keyword>
  <keyword>Parkinson's disease</keyword>
  <keyword>neuromodulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

